OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Internal Medicine is 78. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China	5576
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy	1063
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19	1019
Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset	678
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US	640
Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum	640
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia	575
Is a “Cytokine Storm” Relevant to COVID-19?	549
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia	541
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020	514
Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic	443
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea	403
Trends in Outpatient Care Delivery and Telemedicine During the COVID-19 Pandemic in the US	388
Trends in Emergency Department Visits and Hospital Admissions in Health Care Systems in 5 States in the First Months of the COVID-19 Pandemic in the US	381
Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020	346
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19	345
External Validation of a Widely Implemented Proprietary Sepsis Prediction Model in Hospitalized Patients	336
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19	331
Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China	291
Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity	290
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2	264
Risk Factors Associated With Post−COVID-19 Condition	260
Assessment of Disparities in Digital Access Among Medicare Beneficiaries and Implications for Telemedicine	258
Association Between Healthy Eating Patterns and Risk of Cardiovascular Disease	234
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020	229

What Other Countries Can Learn From Italy During the COVID-19 Pandemic	228
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection	220
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China	193
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US	192
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic	183
Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19	179
Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic	177
Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19	154
Association Between Nursing Home Crowding and COVID-19 Infection and Mortality in Ontario, Canada	151
Clinical Outcomes in Young US Adults Hospitalized With COVID-19	150
COVID-19 in Prisons and Jails in the United States	149
Experiences of Home Health Care Workers in New York City During the Coronavirus Disease 2019 Pandemic	148
Racial and Ethnic Discrepancy in Pulse Oximetry and Delayed Identification of Treatment Eligibility Among Patients With COVID-19	147
Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States	146
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers	144
Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective	142
Efficacy of Smartphone Applications for Smoking Cessation	139
Association Between Plant and Animal Protein Intake and Overall and Cause-Specific Mortality	138
Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure	134
Epidemiologic Trends in Fatal and Nonfatal Firearm Injuries in the US, 2009-2017	130
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine	127
US Public Concerns About the COVID-19 Pandemic From Results of a Survey Given via Social Media	127
Filtration Efficiency of Hospital Face Mask Alternatives Available for Use During the COVID-19 Pandemic	126
Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy	125
Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition	123
Assessment of Deaths From COVID-19 and From Seasonal Influenza	121
Association of Antenatal Diet and Physical Activity–Based Interventions With Gestational Weight Gain and Pregnancy Outcomes	113
Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19	108
Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic	108
Association of Physical Activity Intensity With Mortality	108
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients	105
Prospective Associations of Daily Step Counts and Intensity With Cancer and Cardiovascular Disease Incidence and Mortality and All-Cause Mortality	100
Hospitalizations for Chronic Disease and Acute Conditions in the Time of COVID-19	100
Evaluation of Gender Inequity in Thyroid Cancer Diagnosis	96
Association of Telomere Length With Risk of Disease and Mortality	96
Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine	95
Risk of Progression to Diabetes Among Older Adults With Prediabetes	93
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022	92
Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection	92
Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older	90
Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington	89
Internet Searches for Unproven COVID-19 Therapies in the United States	89
Association of Statin Therapy Initiation With Diabetes Progression	86
The Disproportionate Burden of COVID-19 for Immigrants in the Bronx, New York	86
Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis	84
Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity	84
Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients With Heart Failure	82
Association of Facial Paralysis With mRNA COVID-19 Vaccines	82
Prevalence of Chronic Kidney Disease in China	80
Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19	80

Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States	79
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose	79
Accounting for Age in the Definition of Chronic Kidney Disease	79
Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status	78